BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24186915)

  • 61. Association of natriuretic peptide and adverse outcomes in patients with atrial fibrillation: A meta-analysis.
    Du H; Yang L; Zhang H; Zhang X; Shao H
    Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):161-169. PubMed ID: 33169376
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stress-delta B-type Natriuretic Peptide Levels as a Test for Inducible Myocardial Ischemia: A Systematic Review and Meta-Analysis.
    Kheang S; Rodrigues CG; Vissoci JRN; Hassan A; Muller C; Muller D; Limkakeng AT
    Cureus; 2020 Mar; 12(3):e7165. PubMed ID: 32257708
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Clin Chem Lab Med; 2004 Feb; 42(2):159-63. PubMed ID: 15061354
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic value of a single prehospital measurement of N-terminal pro-brain natriuretic peptide and troponin T after acute ischaemic stroke.
    Hajdinjak E; Klemen P; Grmec S
    J Int Med Res; 2012; 40(2):768-76. PubMed ID: 22613442
    [TBL] [Abstract][Full Text] [Related]  

  • 66. NT-proBNP and BNP values in cardiac patients with different degree of left ventricular systolic dysfunction.
    Kotaska K; Popelova J; Tiserova M; Telekes P; Vrzanova M; Bronsky J; Halacova M; Kukacka J; Prusa R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Jul; 150(1):125-30. PubMed ID: 16936915
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke.
    Jensen JK; Atar D; Kristensen SR; Mickley H; Januzzi JL
    Am J Cardiol; 2009 Jul; 104(2):287-91. PubMed ID: 19576362
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic value of N-terminal pro B-type natriuretic peptide for nonvalvular atrial fibrillation in acute ischemic stroke patients: A retrospective multicenter case-control study.
    Zhao J; Zhang Y; Yuan F; Song C; Jiang Y; Gao Q; Leng X; Jiang W
    J Neurol Sci; 2020 Jul; 414():116822. PubMed ID: 32278166
    [TBL] [Abstract][Full Text] [Related]  

  • 69. N-terminal pro-B-type natriuretic peptide concentrations and long-term outcome after cardiac surgery: a prospective cohort study.
    Cuthbertson BH; Croal BL; Rae D; Harrild K; Gibson PH; Prescott GJ; Kengne AP; Hillis GS
    Br J Anaesth; 2013 Feb; 110(2):214-21. PubMed ID: 23183321
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.
    Kulkarni M; Gokulakrishnan G; Price J; Fernandes CJ; Leeflang M; Pammi M
    Pediatrics; 2015 Feb; 135(2):e510-25. PubMed ID: 25601976
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure.
    Zuber M; Cuculi F; Attenhofer Jost CH; Kipfer P; Buser P; Seifert B; Erne P
    Scand Cardiovasc J; 2009; 43(5):324-9. PubMed ID: 19247872
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Natriuretic peptides in chronic kidney disease.
    Tagore R; Ling LH; Yang H; Daw HY; Chan YH; Sethi SK
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1644-51. PubMed ID: 18632852
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
    Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke.
    Hajsadeghi S; Kashani Amin L; Bakhshandeh H; Rohani M; Azizian AR; Jafarian Kerman SR
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):554-60. PubMed ID: 23422348
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM; Rauh M; Zink S; Singer H
    Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -.
    Sugimoto M; Manabe H; Nakau K; Furuya A; Okushima K; Fujiyasu H; Kakuya F; Goh K; Fujieda K; Kajino H
    Circ J; 2010 May; 74(5):998-1005. PubMed ID: 20378998
    [TBL] [Abstract][Full Text] [Related]  

  • 77. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
    Myhre PL; Vaduganathan M; Claggett B; Packer M; Desai AS; Rouleau JL; Zile MR; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
    J Am Coll Cardiol; 2019 Mar; 73(11):1264-1272. PubMed ID: 30846338
    [TBL] [Abstract][Full Text] [Related]  

  • 78. N-terminal pro-brain natriuretic peptide levels associated with severe hand, foot and mouth disease.
    Deng HL; Zhang YF; Li YP; Zhang Y; Xie Y; Wang J; Wang XY; Dang SS
    BMC Infect Dis; 2016 Oct; 16(1):585. PubMed ID: 27760526
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association of Natriuretic Peptide With Adverse Outcomes and Disease Severity After Intracerebral Hemorrhage: A Systematic Review.
    Wang J; Wang J; Tang Z; Zhang P
    Front Neurol; 2021; 12():775085. PubMed ID: 34867764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.